Form 4 Filing for AVITA Medical, Inc. - Officer/Director Transactions

Michael E. Tarnoff, a director at AVITA Medical, Inc. (RCEL), reported transactions involving the acquisition of securities. On August 6, 2025, Tarnoff was granted 19,063 stock options with an exercise price of $5.36 and 26,250 restricted stock units (RSUs). These RSUs vest in three equal annual installments starting August 2026. On January 20, 2026, Tarnoff received an additional 16,133 stock options with an exercise price of $3.77 and 22,214 RSUs. These RSUs vest one year after the grant date. All grants were subject to and received stockholder approval on June 3, 2026. Following these transactions, Tarnoff holds 19,063 shares directly from the options granted on August 6, 2025, and 48,464 shares directly from the RSUs granted on both dates. The reported post-transaction shares for RSUs are inclusive of unvested units.